Wnt Signaling in IBD-Related Colon Cancer
Wnt Signaling in IBD-Related Colon Cancer
批准号:
6703346
负责人:
RANDALL F HOLCOMBE
金额:
$15.15万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-02-15 至 2006-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Wnt ligands induce a signaling cascade by binding to cell surface frizzled receptors. This leads to increases in cellular beta-catenin and, ultimately, the induction of transcription of growth promoting genes. This process, mimicked by mutations in the APC gene, is integrally associated with the process of sporadic colon carcinogenesis. Mutations in APC and beta-catenin appear to be rare in inflammatory bowel disease (IBD)-related tumors. However, abnormal expression of other components of the Wnt pathway, including frizzled receptors, SARP1 and disheveled (dvl) have been described. In this proposal, the expression of upstream elements of the Wnt signal transduction pathway, frizzled receptors and frizzled inhibitory molecules will be defined in normal, dysplastic and malignant colonic tissues from patients with IBD. First, we will examine the expression of Fz receptors by immunohistochemistry in IBD-associated colon cancer tissues and compare this expression to adjacent mucosal tissues and sporadic colon cancers. In situ hybridization with anti-sense RNA probes specific for each of the ten Fz receptor subtypes as well as for specific frizzled-inhibitory proteins (FIPs) will then be utilized to define their expression in these tissues. Next, colon biopsies of normal and dysplastic mucosa will be obtained prospectively from patients with IBD undergoing surveillance colonoscopy. These tissues will be evaluated for expression of frizzled receptor subtypes and FIPs and also for activation of Wnt signaling, indicated by nuclearization of beta-catenin and increased expression and activity of a downstream pathway component, LEF1. Finally, the role of specific Fz receptor subtypes in the initiation and propagation of Wnt pathway signals will be defined utilizing a novel, in vitro, co-culture expression system. Those Fz receptor subtypes which exhibit differential expression in IBD tissues will be evaluated in this system. Expression constructs for individual Fz receptor subtypes will be utilized for more in-depth analysis in colon cancer cell lines. The precise effects of FIPs on Wnt signaling will be defined in vitro, with attention to the potentially disparate responses of different, specific, Fz receptor subtypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8005456
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8119595
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:8166926
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2009
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:7951074
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2008
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
A Phase 1 Study of CCI-779 in Combination with Imatnib *
-
批准号:7087072
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2005
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6850894
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6327470
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6874525
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7586771
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7097832
-
项目类别:
-
资助金额:$14.58万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6633466
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7251986
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:8182171
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7788097
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6514090
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7386702
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6726005
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9268835
-
项目类别:
-
资助金额:$11.55万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9526161
-
项目类别:
-
资助金额:$215.6万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:10063281
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
国内基金
海外基金
增生性玻璃体视网膜病变早期钙黏蛋白(Cadherins)异常表达启动视网膜色素上皮细胞游离的分子机制
-
批准号:81770939
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:王方
-
依托单位:
Beta-catenin/Cadherins, EphBs 在平衡颅神经嵴细胞的粘附和迁徙机制的研究
-
批准号:81400494
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:刘人恺
-
依托单位:
Cadherins与nectins在青少年期慢性社会应激损害小鼠前额叶形态可塑性与功能中的作用
-
批准号:81401129
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:李继涛
-
依托单位: